212 related articles for article (PubMed ID: 10644069)
1. Sustained release of human growth hormone from PLGA solution depots.
Brodbeck KJ; Pushpala S; McHugh AJ
Pharm Res; 1999 Dec; 16(12):1825-9. PubMed ID: 10644069
[TBL] [Abstract][Full Text] [Related]
2. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
[TBL] [Abstract][Full Text] [Related]
3. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release.
Kim HK; Park TG
Int J Pharm; 2001 Oct; 229(1-2):107-16. PubMed ID: 11604263
[TBL] [Abstract][Full Text] [Related]
5. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer.
Brodbeck KJ; DesNoyer JR; McHugh AJ
J Control Release; 1999 Dec; 62(3):333-44. PubMed ID: 10528071
[TBL] [Abstract][Full Text] [Related]
6. The stabilization and encapsulation of human growth hormone into biodegradable microspheres.
Johnson OL; Jaworowicz W; Cleland JL; Bailey L; Charnis M; Duenas E; Wu C; Shepard D; Magil S; Last T; Jones AJ; Putney SD
Pharm Res; 1997 Jun; 14(6):730-5. PubMed ID: 9210189
[TBL] [Abstract][Full Text] [Related]
7. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
Cleland JL; Jones AJ
Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
[TBL] [Abstract][Full Text] [Related]
8. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
[TBL] [Abstract][Full Text] [Related]
9. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
12. Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo.
Yin D; Lu Y; Zhang H; Zhang G; Zou H; Sun D; Zhong Y
Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):156-61. PubMed ID: 18239299
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
14. Solid/Hollow depots for drug delivery, part 1: effect of drug characteristics and polymer molecular weight on the phase-inversion dynamics, depot morphology, and drug release.
Liu H; Venkatraman SS
J Pharm Sci; 2014 Feb; 103(2):485-95. PubMed ID: 24357252
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres.
Schutzman R; Shi NQ; Olsen KF; Ackermann R; Tang J; Liu YY; Hong JKY; Wang Y; Qin B; Schwendeman A; Schwendeman SP
J Control Release; 2023 Sep; 361():297-313. PubMed ID: 37343723
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.
Rafi M; Singh SM; Kanchan V; Anish CK; Panda AK
J Microencapsul; 2010; 27(6):552-60. PubMed ID: 20690791
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
18. Determinants of release rate of tetanus vaccine from polyester microspheres.
Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
[TBL] [Abstract][Full Text] [Related]
19. Characterization and in vivo study of sustained-release formulation of human growth hormone using sodium hyaluronate.
Hahn SK; Kim SJ; Kim MJ; Kim DH
Pharm Res; 2004 Aug; 21(8):1374-81. PubMed ID: 15359571
[TBL] [Abstract][Full Text] [Related]
20. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
